» Articles » PMID: 25535351

Only Three Driver Gene Mutations Are Required for the Development of Lung and Colorectal Cancers

Overview
Specialty Science
Date 2014 Dec 24
PMID 25535351
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer arises through the sequential accumulation of mutations in oncogenes and tumor suppressor genes. However, how many such mutations are required for a normal human cell to progress to an advanced cancer? The best estimates for this number have been provided by mathematical models based on the relation between age and incidence. For example, the classic studies of Nordling [Nordling CO (1953) Br J Cancer 7(1):68-72] and Armitage and Doll [Armitage P, Doll R (1954) Br J Cancer 8(1):1-12] suggest that six or seven sequential mutations are required. Here, we describe a different approach to derive this estimate that combines conventional epidemiologic studies with genome-wide sequencing data: incidence data for different groups of patients with the same cancer type were compared with respect to their somatic mutation rates. In two well-documented cancer types (lung and colon adenocarcinomas), we find that only three sequential mutations are required to develop cancer. This conclusion deepens our understanding of the process of carcinogenesis and has important implications for the design of future cancer genome-sequencing efforts.

Citing Articles

Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms.

Sohel H, Kiyono T, Zahan U, Razia S, Ishikawa M, Yamashita H Int J Mol Sci. 2025; 26(5).

PMID: 40076621 PMC: 11901000. DOI: 10.3390/ijms26051995.


SATB1 in cancer progression and metastasis: mechanisms and therapeutic potential.

Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W Front Oncol. 2025; 15:1535929.

PMID: 40071088 PMC: 11893431. DOI: 10.3389/fonc.2025.1535929.


Mesenchymal stem cells modulate breast cancer progression through their secretome by downregulating ten-eleven translocation 1.

Motamed R, Jabbari K, Sheikhbahaei M, Ghazimoradi M, Ghodsi S, Jahangir M Sci Rep. 2025; 15(1):6593.

PMID: 39994414 PMC: 11850621. DOI: 10.1038/s41598-025-91314-3.


Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities.

Zhang J, Zhang J, Yang C J Transl Med. 2025; 23(1):52.

PMID: 39806481 PMC: 11727735. DOI: 10.1186/s12967-024-06063-0.


MODELING EARLY-ONSET CANCER KINETICS TO STUDY CHANGES IN UNDERLYING RISK, DETECTION, AND IMPACT OF POPULATION SCREENING.

Mirzaei N, Hur C, Terry M, Dalerba P, Yang W medRxiv. 2024; .

PMID: 39677417 PMC: 11643252. DOI: 10.1101/2024.12.05.24318584.


References
1.
Moolgavkar S, Dewanji A, Venzon D . A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal. 1988; 8(3):383-92. DOI: 10.1111/j.1539-6924.1988.tb00502.x. View

2.
NORDLING C . A new theory on cancer-inducing mechanism. Br J Cancer. 1953; 7(1):68-72. PMC: 2007872. DOI: 10.1038/bjc.1953.8. View

3.
Little M . Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics. 1995; 51(4):1278-91. View

4.
Jackson A, Loeb L . The mutation rate and cancer. Genetics. 1998; 148(4):1483-90. PMC: 1460096. DOI: 10.1093/genetics/148.4.1483. View

5.
Moolgavkar S, Luebeck E . Multistage carcinogenesis: population-based model for colon cancer. J Natl Cancer Inst. 1992; 84(8):610-8. DOI: 10.1093/jnci/84.8.610. View